デフォルト表紙
市場調査レポート
商品コード
1492518

セフラジン市場:製剤、用途、流通チャネル別-2024-2030年の世界予測

Cephradine Market by Formulation (Capsules, Injectable, Oral Suspension), Application (Respiratory Tract Infections, Skin & Structure Infections, Urinary Tract Infections), Distribution Channel - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
セフラジン市場:製剤、用途、流通チャネル別-2024-2030年の世界予測
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

セフラジン市場規模は、2023年に4億4,157万米ドルと推定され、2024年には4億5,376万米ドルに達し、CAGR 2.91%で2030年には5億4,013万米ドルに達すると予測されています。

セフラジンはセファロスポリン系に属する抗生物質の一種で、細菌が細胞壁を形成する能力を阻害することで細菌を死滅させ、細菌感染治療に使用されます。セフラジンの使用増加の要因としては、皮膚感染症、尿路感染症、呼吸器感染症など、さまざまな細菌感染症の治療に有効であることが挙げられます。さらに、より強力な抗生物質と比較して、患者の忍容性が比較的高いことも、臨床使用における人気の一因となっています。しかし、セファロスポリン系抗菌薬に過敏な患者ではアレルギー反応を起こす可能性があり、その過剰使用は抗生物質耐性菌の発生につながり、公衆衛生上の重大かつ深刻な問題となっています。とはいえ、一般的な副作用を軽減したり、薬剤の有効性を向上させたりするような製剤の改良によって、その受容性と使用率が向上すれば、採用が増える可能性があります。耐性を緩和し、有効性を高める可能性のある併用療法の調査も、新たな市場機会をもたらすかもしれません。

主な市場の統計
基準年[2023] 4億4,157万米ドル
予測年[2024] 4億5,376万米ドル
予測年 [2030] 5億4,013万米ドル
CAGR(%) 2.91%

地域別インサイト

米国を中心とする南北アメリカにおいて、セフラジン市場は厳しい規制基準と、臨床現場での確実な流通と使用を保証する確立されたヘルスケアインフラの影響を受けています。抗生物質耐性との闘いに大きな焦点が当てられており、セフラジンのような抗生物質の処方方法にも影響を及ぼしています。欧州・中東・アフリカ地域では、経済、ヘルスケア、規制環境が多様であるため、市場力学は大きく異なります。欧州諸国では、強力なヘルスケアシステムと政府の積極的なヘルスケア政策により、新しく効果的な治療法の採用率が高いことが多いです。しかし中東・アフリカ地域では、医療に対する意識が高まり、医療行為もある程度改善されているもの、医療制度があまり発達しておらず、治療へのアクセスもさまざまであるため、市場の成長は制約されています。アジア太平洋地域では、医療費の増加と健康問題に対する意識の高まりにより、情勢が拡大しています。人口が多く、医療インフラが改善されている中国やインドなどの国々は、セフラジン拡大の大きなチャンスを提供しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはセフラジンにおけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、事業戦略や製品満足度に関連する重要な指標を調査します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront(F)、Pathfinder(P)、Niche(N)、Vital(V)に分類されます。

市場シェア分析

市場シェア分析は、セフラジンにおけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。

戦略分析と推奨

戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、セフラジンにおける現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で細菌感染症の蔓延が増加
      • 細菌感染症の治療における個別化医療への傾向の高まり
    • 抑制要因
      • セフラジンの潜在的な悪影響や副作用に関する懸念
    • 機会
      • 有効性と利便性を高めるドラッグデリバリーメカニズムの革新
      • 新しい処方を発見するための研究開発への継続的な投資
    • 課題
      • さまざまな地域にわたる厳格な規制基準とコンプライアンス要件
  • 市場セグメンテーション分析
    • 製剤:迅速な対応のための臨床現場におけるセフラジンの注射剤の適合性
    • 用途:細菌酵素に対する耐性による呼吸器感染症の有効性
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 セフラジン市場:製剤別

  • カプセル
  • 注射可能
  • 経口懸濁液

第7章 セフラジン市場:用途別

  • 呼吸器感染症
  • 皮膚および構造感染症
  • 尿路感染症

第8章 セフラジン市場:流通チャネル別

  • 病院薬局
  • オンライン薬局
  • 小売薬局

第9章 南北アメリカのセフラジン

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域のセフラジン

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのセフラジン

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析(2023年)
  • FPNVポジショニングマトリックス(2023年)
  • 競合シナリオ分析
    • 抗菌薬耐性への対応:FDAが新しい抗生物質セフトビプロールを承認
    • FDAはVenatorxとMelintaの抗生物質NDAに関する追加データを要求
  • 戦略分析と提言

第13章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. CEPHRADINE MARKET RESEARCH PROCESS
  • FIGURE 2. CEPHRADINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CEPHRADINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CEPHRADINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CEPHRADINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CEPHRADINE MARKET DYNAMICS
  • FIGURE 7. GLOBAL CEPHRADINE MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CEPHRADINE MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CEPHRADINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CEPHRADINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CEPHRADINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CEPHRADINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CEPHRADINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CEPHRADINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CEPHRADINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CEPHRADINE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CEPHRADINE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CEPHRADINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CEPHRADINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CEPHRADINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CEPHRADINE MARKET SIZE, BY CAPSULES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CEPHRADINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CEPHRADINE MARKET SIZE, BY INJECTABLE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CEPHRADINE MARKET SIZE, BY ORAL SUSPENSION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CEPHRADINE MARKET SIZE, BY ORAL SUSPENSION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CEPHRADINE MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CEPHRADINE MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CEPHRADINE MARKET SIZE, BY SKIN & STRUCTURE INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CEPHRADINE MARKET SIZE, BY SKIN & STRUCTURE INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CEPHRADINE MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CEPHRADINE MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CEPHRADINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CEPHRADINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CEPHRADINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CEPHRADINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CEPHRADINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CEPHRADINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS CEPHRADINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS CEPHRADINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. BRAZIL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 50. BRAZIL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. CANADA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 56. CANADA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. MEXICO CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 62. MEXICO CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CEPHRADINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES CEPHRADINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 84. AUSTRALIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. CHINA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 90. CHINA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. INDIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 96. INDIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. INDONESIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 102. INDONESIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. JAPAN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 108. JAPAN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. MALAYSIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 114. MALAYSIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 120. PHILIPPINES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. SINGAPORE CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 126. SINGAPORE CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 132. SOUTH KOREA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. TAIWAN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 138. TAIWAN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. THAILAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 144. THAILAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. VIETNAM CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 150. VIETNAM CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. DENMARK CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 164. DENMARK CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. EGYPT CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 170. EGYPT CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. FINLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 176. FINLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. FRANCE CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 182. FRANCE CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. GERMANY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 188. GERMANY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. ISRAEL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 194. ISRAEL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. ITALY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 200. ITALY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 206. NETHERLANDS CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. NIGERIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 212. NIGERIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. NORWAY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 218. NORWAY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. POLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 224. POLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. QATAR CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 230. QATAR CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. RUSSIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 236. RUSSIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 242. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SPAIN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 254. SPAIN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. SWEDEN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 260. SWEDEN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 266. SWITZERLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. TURKEY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 272. TURKEY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 285. CEPHRADINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 286. CEPHRADINE MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-5D693B46BFF9

[184 Pages Report] The Cephradine Market size was estimated at USD 441.57 million in 2023 and expected to reach USD 453.76 million in 2024, at a CAGR 2.91% to reach USD 540.13 million by 2030.

Cephradine is a type of antibiotic that belongs to the cephalosporin class, used in bacterial infections treatment by impeding the bacteria's ability to form cell walls, which results in bacterial death. The factors contributing to the increased use of Cephradine include its effectiveness in treating a range of bacterial infections including skin infections, urinary tract infections, and respiratory tract infections. Additionally, its relatively well-tolerated nature by patients compared to more potent antibiotics contributes to its popularity in clinical use. However, potential allergic reactions in individuals sensitive to cephalosporins and their overuse lead to the development of antibiotic-resistant bacteria, a significant and growing public health issue. Nevertheless, formulation enhancements that reduce common side effects or improve the efficacy of the drug, thereby boosting its acceptability and usage, may increase its adoption. Research into combination therapies that could potentially mitigate resistance and increase effectiveness might also present new market opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 441.57 million
Estimated Year [2024] USD 453.76 million
Forecast Year [2030] USD 540.13 million
CAGR (%) 2.91%

Regional Insights

In the Americas, particularly the United States, the Cephradine market is influenced by stringent regulatory standards and a well-established healthcare infrastructure that ensures its reliable distribution and usage in clinical settings. There is a significant focus on combating antibiotic resistance, which affects how antibiotics such as cephradine are prescribed. In the EMEA region, market dynamics vary widely due to the diverse economic, healthcare, and regulatory environments. European countries often see a high adoption rate of new and effective treatments due to strong healthcare systems and active governmental healthcare policies. However, in the Middle East and Africa, the market growth is constrained by less-developed healthcare systems and varying degrees of access to medical treatments, although there is growing awareness and some improvement in healthcare practices. The Asia Pacific region showcases a growing landscape for cephradine, driven by increasing healthcare expenditures and growing awareness of health issues. Countries including China and India, with their large populations and improving healthcare infrastructure, offer significant opportunities for the expansion of the Cephradine market.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Cephradine Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing prevalence of bacterial infections worldwide
      • Rising trend toward personalized medicine for the treatment of bacterial infections
    • Market Restraints
      • Concerns over potential adverse effects or side effects of cephradine
    • Market Opportunities
      • Innovations in drug delivery mechanisms to enhance the efficacy and convenience
      • Continued investments in research and development to discover new formulations
    • Market Challenges
      • Strict regulatory standards and compliance requirements across different regions
  • Market Segmentation Analysis
    • Formulation: Suitability of injectable form of Cephradine in clinical settings for rapid response
    • Application: Effectiveness of cephradine respiratory tract infections due to its ability to withstand bacterial enzymes
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cephradine Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cephradine Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Addressing Antimicrobial Resistance: FDA Approves New Antibiotic Ceftobiprole

In response to the escalating threat of antimicrobial resistance (AMR), the FDA recently approved a novel antibiotic, Zevtera (ceftobiprole medocaril sodium for injection), which enhances the arsenal against stubborn infections. Zevtera is sanctioned for treating adults with Staphylococcus aureus bloodstream infections, including right-sided infective endocarditis, severe bacterial skin infections, and bacterial pneumonia in both adults and older infants. [Published On: 2024-04-04]

FDA Requests Additional Data for Venatorx and Melinta's Antibiotic NDA

Venatorx Pharmaceuticals and Melinta Therapeutics have received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) concerning their New Drug Application for cefepime-taniborbactam, designed to treat complicated urinary tract infections in adults, including acute pyelonephritis. Both companies expressed their commitment to fulfilling the FDA's requests swiftly. [Published On: 2023-02-23]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cephradine Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Cephradine Market, highlighting leading vendors and their innovative profiles. These include Bristol-Myers Squibb Company, Corden Pharma GmbH, E.R. Squibb & Sons, L.L.C., Fengchen Group Co.,Ltd, GlaxoSmithKline PLC, Hanmi Pharm.Co.,Ltd., Livzon Pharmaceutical Group Co., Lupin Limited, Qilu Pharmaceutical Co., Ltd., Sandoz Group AG, SimSon Pharma Limited, Taj Pharmaceuticals Limited, and Teva Pharmaceuticals.

Market Segmentation & Coverage

This research report categorizes the Cephradine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Formulation
    • Capsules
    • Injectable
    • Oral Suspension
  • Application
    • Respiratory Tract Infections
    • Skin & Structure Infections
    • Urinary Tract Infections
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of bacterial infections worldwide
      • 5.1.1.2. Rising trend toward personalized medicine for the treatment of bacterial infections
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns over potential adverse effects or side effects of cephradine
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations in drug delivery mechanisms to enhance the efficacy and convenience
      • 5.1.3.2. Continued investments in research and development to discover new formulations
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory standards and compliance requirements across different regions
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Formulation: Suitability of injectable form of Cephradine in clinical settings for rapid response
    • 5.2.2. Application: Effectiveness of cephradine respiratory tract infections due to its ability to withstand bacterial enzymes
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Cephradine Market, by Formulation

  • 6.1. Introduction
  • 6.2. Capsules
  • 6.3. Injectable
  • 6.4. Oral Suspension

7. Cephradine Market, by Application

  • 7.1. Introduction
  • 7.2. Respiratory Tract Infections
  • 7.3. Skin & Structure Infections
  • 7.4. Urinary Tract Infections

8. Cephradine Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Cephradine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cephradine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cephradine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Addressing Antimicrobial Resistance: FDA Approves New Antibiotic Ceftobiprole
    • 12.3.2. FDA Requests Additional Data for Venatorx and Melinta's Antibiotic NDA
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio